Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Edjah Nduom"'
Autor:
Guangyang Yu, Madison K. Butler, Abdalla Abdelmaksoud, Ying Pang, Yu-Ting Su, Zachary Rae, Kimia Dadkhah, Michael C. Kelly, Young K. Song, Jun S. Wei, Masaki Terabe, Ramya Atony, Kelly Mentges, Brett J. Theeler, Marta Penas-Prado, John Butman, Kevin Camphausen, Kareem A. Zaghloul, Edjah Nduom, Martha Quezado, Kenneth Aldape, Terri S. Armstrong, Mark R. Gilbert, James L. Gulley, Javed Khan, Jing Wu
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Glioma is the most common primary malignant brain tumor with a poor prognosis. Immune checkpoint inhibitors have been of great interest in investigation of glioma treatments. Here, we report single-cell transcriptomic analyses of two tumor areas from
Externí odkaz:
https://doaj.org/article/7e88b54b897a4be99451920408fb52e0
Autor:
Surabhi Ranjan, Martha Quezado, Nancy Garren, Lisa Boris, Christine Siegel, Osorio Lopes Abath Neto, Brett J. Theeler, Deric M. Park, Edjah Nduom, Kareem A. Zaghloul, Mark R. Gilbert, Jing Wu
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Immune checkpoint inhibitors (ICPIs) are being investigated in clinical trials for patients with glioblastoma. While these therapies hold great promise, management of the patients receiving such treatment can be complicated due to
Externí odkaz:
https://doaj.org/article/6469175576734a80abd564c4cc0fe604
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Glioblastoma is in need of innovative treatment approaches. Immune therapy for cancer refers to the use of the body's immune system to target malignant cells in the body. Such immune therapeutics have recently been very successful in treating a diver
Externí odkaz:
https://doaj.org/article/7d09d1a681474260921b3a8cd93dd525
Autor:
Zachary Buchwald, Caroline Jansen, Roshan Prabhu, Meghana Pagadala, Prasanthi Chappa, Subir Goyal, Chengjing Zhou, Stewart Neill, Nataliya Prokhnevska, Maria Cardenas, Kimberley Hoang, Jim Zhong, Suzanna Logan, Jeffrey Olson, Edjah Nduom, Luke del Balzo, Kirtesh Patel, Stuart Burri, Anthony Asher, Scott Wilkinson, Ross Lake, Kristin Higgins, Pretesh Patel, Vishal Dhere, Adam Sowalsky, Mohammad Khan, Haydn Kissick
The CD8+ T-cell response is prognostic for survival outcomes in several tumor types. However, whether this extends to tumors in the brain, an organ with barriers to T cell entry, remains unclear. Here, we analyzed immune infiltration in 67 brain meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffd667c4007212129e0710514d36b6e8
https://doi.org/10.21203/rs.3.rs-2722744/v1
https://doi.org/10.21203/rs.3.rs-2722744/v1
Autor:
Caroline Jansen, Prasanthi Chappa, Nataliya Prokhnevska, Maria Cardenas, Roshan Prabhu, Jim Zhong, Kimberly Hoang, Subir Goyal, Suzanna Logan, Jeffrey Olson, Edjah Nduom, Luke del Balzo, Kirtesh Patel, Stuart Burri, Anthony Asher, Scott Wilkinson, Ross Lake, Kristin Higgins, Pretesh Patel, Vishal Dhere, Mylin Torres, Adam Sowalsky, Mohammad Khan, Haydn Kissick, Zachary Buchwald
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff61faed60b06dc418b8a133cb6115c4
https://doi.org/10.1136/jitc-2022-sitc2022.1033
https://doi.org/10.1136/jitc-2022-sitc2022.1033
Publikováno v:
Neurooncol Adv
Background Brain microdialysis is a minimally invasive technique for monitoring analytes, metabolites, drugs, neurotransmitters, and/or cytokines. Studies to date have centered on adults with traumatic brain injury, with a limited number of pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074aa83beefbeb0051e2f3e69b6b39cf
https://europepmc.org/articles/PMC9683385/
https://europepmc.org/articles/PMC9683385/
Autor:
Caple A. Spence, Sonia V. Eden, Brenton Pennicooke, Owoicho Adogwa, Langston T. Holly, Babu G. Welch, Nnenna Mbabuike, Edjah Nduom, William W. Ashley
Publikováno v:
Journal of neurosurgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d293cc07944dd2ae9709ba39b3ce729
https://pubmed.ncbi.nlm.nih.gov/36087322
https://pubmed.ncbi.nlm.nih.gov/36087322
Autor:
Benjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, Caroline Chung, Howard Colman, Patricia E Cole, David Leung, Joshua E Allen, Manmeet S Ahluwalia, Jerrold Boxerman, Matthew Brown, Jonathan Goldin, Edjah Nduom, Islam Hassan, Mark R Gilbert, Ingo K Mellinghoff, Michael Weller, Susan Chang, David Arons, Clair Meehan, Wendy Selig, Kirk Tanner, W K Alfred Yung, Martin van den Bent, Patrick Y Wen, Timothy F Cloughesy
Publikováno v:
Neuro Oncol
Neuro-oncology, vol 24, iss 8
Neuro-Oncology, 24(8), 1219-1229. Oxford University Press
Neuro-oncology, vol 24, iss 8
Neuro-Oncology, 24(8), 1219-1229. Oxford University Press
Imaging response assessment is a cornerstone of patient care and drug development in oncology. Clinicians/clinical researchers rely on tumor imaging to estimate the impact of new treatments and guide decision making for patients and candidate therapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4049c6f96093e9e7806de96c81259463
https://europepmc.org/articles/PMC9340639/
https://europepmc.org/articles/PMC9340639/
Publikováno v:
Neuro-Oncology Advances. 4:i6-i7
INTRODUCTION Diffuse midline gliomas are the most aggressive brain tumors of childhood and young adults, with documented 2 year survival rates of METHODS All participants will take abemaciclib pre-operatively for 4.5 days at twice daily dosing. A max
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0743b8d386e3c82b5cc05bd23c477ae6
https://doi.org/10.1093/noajnl/vdac078.025
https://doi.org/10.1093/noajnl/vdac078.025
Autor:
Lisa Sudmeier, Kimberly B. Hoang, Edjah Nduom, Subir Goyal, Yuan Liu, Jeffrey J. Olson, Suresh S. Ramalingam, Rafi Ahmed
Publikováno v:
Journal of Clinical Oncology. 40:e15075-e15075
e15075 Background: Nearly all patients who develop large and/or symptomatic brain metastases receive corticosteroids such as dexamethasone (Dex) to treat or prevent symptoms like nausea, headaches, or focal neurologic deficits. Dex has immunosuppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e230d5e99836b3fba50e65b69aa4a692
https://doi.org/10.1200/jco.2022.40.16_suppl.e15075
https://doi.org/10.1200/jco.2022.40.16_suppl.e15075